Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

January 31, 2004

Conditions
Gastrointestinal Stromal TumorSarcoma
Interventions
DRUG

brostallicin

Trial Locations (16)

13385

CHU de la Timone, Marseille

69008

Centre Leon Berard, Lyon

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

F-94805

Institut Gustave Roussy, Villejuif

D-13122

Robert Roessle Klinik, Berlin

D-20246

Universitaets-Krankenhaus Eppendorf, Hamburg

D-30625

Medizinische Hochschule Hannover, Hanover

D-81377

Klinikum Grosshadern der Ludwig-Maximilians Universitaet Muenchen, Munich

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

9700 RB

Academisch Ziekenhuis Groningen, Groningen

2300 RC

Leiden University Medical Center, Leiden

3008 AE

Daniel Den Hoed Cancer Center at Erasmus University Medical Center, Rotterdam

LS9 7TF

St. James's University Hospital, Leeds

SW3 6JJ

Royal Marsden NHS Trust - London, London

NE4 6BE

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00041249 - Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter